Search results
Apple Intelligence, Musk Reacts, Equal-Weighted S&P Signal? Trading Moderna
TheStreet.com· 5 days agoThe goal on Monday was probably to convince investors that Apple is not falling way behind in the...
Combo COVID/flu vaccine elicits higher immune response in trial
UPI· 6 days agoThe new vaccine contains components of mRNA-1010, Moderna's vaccine candidate for seasonal...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoAt the midpoints, earnings would climb more than 22% as sales rise almost 3%. Pfizer Stock And...
Midday movers: Southwest Airlines, CrowdStrike, KKR rise; AMD falls
Investing.com via Yahoo Finance· 6 days agoModerna (NASDAQ:MRNA) (MRNA) stock fell 2.8% despite the biotech company announcing its combination vaccine, which targets both Covid-19 and the flu, was ...
Daily Brief: Apple’s AI strategy
Quartz· 6 days ago“Apple Intelligence” is a new collection of AI features that is focused on personal products, and privacy is a huge goal of executives.
Futures dip on caution ahead of inflation data, Fed meeting
MSN News· 6 days agoBy Lisa Pauline Mattackal and Johann M Cherian (Reuters) -U.S. stock index futures edged lower on...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 5 days agoWith its stock price fast approaching $1000 per share, drugmaker Eli lilly is poised for a forward ...
Midday movers: Southwest Airlines, CrowdStrike, KKR rise; AMD falls By Investing.com
Investing.com· 6 days agoMidday movers: Southwest Airlines, CrowdStrike, KKR rise; AMD falls
Sarepta’s stock gains after Pfizer’s Duchenne trial failure - Boston Business Journal
The Business Journals· 3 days agoSarepta Therapeutics, a Cambridge drugmaker known for its Duchenne muscular dystrophy treatments,...
Worried you missed the Nvidia bandwagon? Here are some alternatives.
Market Watch· 1 day agoIs it too late for investors to jump on the Nvidia bandwagon? Maybe, but there are some alternative...